W43 (Rosiglitazone Maleate 8 mg (base))
Pill with imprint W43 is Red, Elliptical / Oval and has been identified as Rosiglitazone maleate 8 mg (base). It is supplied by West-ward Pharmaceutical Corp..
Rosiglitazone is used in the treatment of diabetes, type 2; nonalcoholic fatty liver disease and belongs to the drug class thiazolidinediones. Risk cannot be ruled out during pregnancy. Rosiglitazone 8 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).
Images for W43
Rosiglitazone maleate
- Imprint:
- W43
- Strength:
- 8 mg (base)
- Color:
- Red
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Thiazolidinediones
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- West-ward Pharmaceutical Corp.
- National Drug Code (NDC):
- 00143-9975
More about rosiglitazone
- Rosiglitazone Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Interactions
- Support Group
- En Español
- 8 Reviews
- Drug class: thiazolidinediones
Consumer resources
Other brands: Avandia
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
